National Synovial Sarcoma Tumor Board Gains Widespread Adoption
The National Synovial Sarcoma Tumor Board, funded by the Spence Family Synovial Sarcoma Foundation, has become an essential collaborative hub for leading medical institutions across the country. This initiative, launched in partnership with CHOP and Penn Medicine, brings together top specialists to discuss complex Synovial Sarcoma cases, ensuring that patients receive expert-reviewed treatment recommendations regardless of where they receive care.
The Tumor Board operates as a virtual platform, allowing oncologists, surgeons, radiologists, and pathologists to share their expertise, analyze challenging cases, and standardize treatment approaches. By fostering multidisciplinary collaboration, this initiative is helping to improve clinical decision-making, refine best practices, and ultimately enhance patient outcomes.
Since its launch, participation in the Tumor Board has continued to expand, with a growing list of prestigious hospitals and cancer centers contributing to this nationwide effort. The current participating institutions include:
- Atrium Health – North Carolina
- Barnes and Jewish Hospital – Missouri
- Cancer Care Manitoba – Manitoba
- Children’s Hospital Colorado – Colorado
- Children’s Hospital Medical Center of Akron – Ohio
- Children’s Hospital of Philadelphia (CHOP) – Pennsylvania
- City of Hope – California
- Cleveland Clinic – Ohio
- Dana-Farber/Harvard Cancer Center – Massachusetts
- Dell Children’s Medical Center of Central Texas – Texas
- Duke Health – North Carolina
- Johns Hopkins – Maryland
- Lucile Packard Children’s Hospital Stanford University – California
- Maine Health – Maine
- Mayo Clinic Arizona – Arizona
- MD Anderson Cancer Center – Texas
- MD Anderson in Phoenix – Arizona
- Memorial Sloan Kettering Cancer Center – New York
- Nationwide Children’s Hospital – Ohio
- Northwestern Medicine – Illinois
- Penn Medicine – Pennsylvania
- Roswell Park Comprehensive Cancer Center – New York
- Seattle Children’s Hospital – Washington
- Stanford – California
- UCLA – California
- University of Alabama at Birmingham – Alabama
- University of Colorado – Colorado
- University of Minnesota/Masonic Cancer Center – Minnesota
- University of Utah Health/Primary Children’s Hospital – Utah
- UT Southwestern/Simmons Cancer Center-Dallas – Texas
Through this unified approach, the Tumor Board is shaping the future of Synovial Sarcoma treatment, providing more equitable access to expertise and improving treatment options for patients nationwide.
The Spence Family Synovial Sarcoma Foundation remains committed to expanding this effort, ensuring that all patients—regardless of location—have access to expert-driven treatment recommendations.
For more information, visit: [LINK TO PAGE ON SITE]
